BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1345 related articles for article (PubMed ID: 11155451)

  • 1. [Magnetic resonance imaging of hepatic focal lesions: dynamic contrastographic evaluation with gadolinium versus reticulo-endothelial hepato-specific contrast media].
    Di Cesare E; Cariello G; Barile A; Sabatini M; Michelini O; Erriquez D; Masciocchi C
    Radiol Med; 2000 Oct; 100(4):245-50. PubMed ID: 11155451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times.
    Kim JH; Kim MJ; Suh SH; Chung JJ; Yoo HS; Lee JT
    J Magn Reson Imaging; 2002 May; 15(5):573-83. PubMed ID: 11997899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging.
    Lutz AM; Willmann JK; Goepfert K; Marincek B; Weishaupt D
    Radiology; 2005 Nov; 237(2):520-8. PubMed ID: 16192317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Focal liver lesions. A comparison between magnetic resonance under base conditions and after a superparamagentic contrast medium].
    Finazzo M; Midiri M; Gallo C; Bartolotta TV; Luca A
    Radiol Med; 1998 Jun; 95(6):599-607. PubMed ID: 9717542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superparamagnetic iron oxide--enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions.
    Vogl TJ; Hammerstingl R; Schwarz W; Mack MG; Müller PK; Pegios W; Keck H; Eibl-Eibesfeldt A; Hoelzl J; Woessmer B; Bergman C; Felix R
    Radiology; 1996 Mar; 198(3):881-7. PubMed ID: 8628887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.
    Grazioli L; Morana G; Kirchin MA; Schneider G
    Radiology; 2005 Jul; 236(1):166-77. PubMed ID: 15955857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison.
    Grazioli L; Morana G; Kirchin MA; Caccia P; Romanini L; Bondioni MP; Procacci C; Chiesa A
    J Magn Reson Imaging; 2003 May; 17(5):593-602. PubMed ID: 12720270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal nodular hyperplasia of the liver: detection and characterization with plain and dynamic-enhanced MRI.
    Mortelé KJ; Praet M; Van Vlierberghe H; de Hemptinne B; Zou K; Ros PR
    Abdom Imaging; 2002; 27(6):700-7. PubMed ID: 12395259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
    Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
    Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and characterization of focal liver lesions using superparamagnetic iron oxide-enhanced magnetic resonance imaging: comparison between ferumoxides-enhanced T1-weighted imaging and delayed-phase gadolinium-enhanced T1-weighted imaging.
    Takahama K; Amano Y; Hayashi H; Ishihara M; Kumazaki T
    Abdom Imaging; 2003; 28(4):525-30. PubMed ID: 14580096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227).
    Saini S; Edelman RR; Sharma P; Li W; Mayo-Smith W; Slater GJ; Eisenberg PJ; Hahn PF
    AJR Am J Roentgenol; 1995 May; 164(5):1147-52. PubMed ID: 7717222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical focal nodular hyperplasia of the liver: imaging features of nonspecific and liver-specific MR contrast agents.
    Ba-Ssalamah A; Schima W; Schmook MT; Linnau KF; Schibany N; Helbich T; Reimer P; Laengle F; Wrba F; Kurtaran A; Ryan M; Mann FA
    AJR Am J Roentgenol; 2002 Dec; 179(6):1447-56. PubMed ID: 12438034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity.
    Tanabe M; Ito K; Shimizu A; Fujita T; Onoda H; Yamatogi S; Washida Y; Matsunaga N
    Magn Reson Imaging; 2009 Jul; 27(6):801-6. PubMed ID: 19144487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging.
    Lee JM; Kim CS; Youk JH; Lee MS
    Korean J Radiol; 2003; 4(1):9-18. PubMed ID: 12679629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dynamic and static MRI using superparamagnetic MRI contrast medium Resovist for visualizing primary and secondary liver tumors].
    Vogl TJ; Schwarz W; Hammerstingl R; Kümmel S; Balzer JO; Mack MG; Diebold T; Balzer T; Shamsi K; Bechstein WO; Schrem H; Neuhaus P; Felix R
    Rofo; 1997 Sep; 167(3):264-73. PubMed ID: 9376555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA].
    Olivetti L; Grazioli L; Maroldi R; Matricardi L; Milanesio L
    Radiol Med; 1992 Apr; 83(4):353-60. PubMed ID: 1318558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of liver hemangiomas from metastases and hepatocellular carcinoma at MR imaging enhanced with blood-pool contrast agent Code-7227.
    Harisinghani MG; Saini S; Weissleder R; Halpern EF; Schima W; Rubin DL; Stillman AE; Sica GT; Small WC; Hahn PF
    Radiology; 1997 Mar; 202(3):687-91. PubMed ID: 9051017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR imaging patterns of gadolinium retention within liver neoplasms.
    Peterson MS; Murakami T; Baron RL
    Abdom Imaging; 1998; 23(6):592-9. PubMed ID: 9922191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differential diagnosis of focal liver lesions with MRI using the superparamagnetic contrast medium endorem].
    Vogl TJ; Hammerstingl R; Keck H; Felix R
    Radiologe; 1995 Nov; 35(11 Suppl 2):S258-66. PubMed ID: 8588032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images.
    Kelekis NL; Semelka RC; Worawattanakul S; de Lange EE; Ascher SM; Ahn IO; Reinhold C; Remer EM; Brown JJ; Bis KG; Woosley JT; Mitchell DG
    AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.